Skip to main content
. 2022 Apr 1;2022(4):CD013554. doi: 10.1002/14651858.CD013554.pub2

Comparison 1. Tissue plasminogen activator‐antibiotic lock treatment versus heparin‐antibiotic lock treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Short‐term success 1 24 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.74, 1.15]
1.2 Long‐term success 1 24 Risk Ratio (M‐H, Random, 95% CI) 0.64 [0.38, 1.06]
1.3 Infection‐free survival 1 24 Mean Difference (IV, Random, 95% CI) ‐27.70 [‐88.68, 33.28]